• MDS Congress 2026 Session 5207 Evaluation Form

  • Plenary Session 5207

    Parkinson's Disease Fluid and Tissue Biomarkers and Biological Frameworks

    October 8, 2026

    08:00 - 09:30

  • Learning Objectives:

    1. Interpret emerging data on fluid biomarkers such as quantitative seed amplification, proteomics and protein biomarkers
    2. Describe progress in tissue biomarkers for Parkinson’s disease
    3. Recognize the uses and limitations of biomarkers for diagnosis and monitoring and their different roles in research and clinical care

  • Session Evaluation

  • The session met its learning objectives
  • The content is relevant to my professional and / or scientific interests.
  • The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.
  • The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.
  • The overall session organization was satisfactory and appropriate.
  • I would recommend this session to a colleague.

  • Faculty Assessment

  • Taku Hatano, Japan

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • David Coughlin, USA

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Claudia Trenkwalder, Germany

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.
  • The following category best describes your current major professional activity (choose one):

  • Should be Empty: